Diagnostic and Prognostic Accuracy of MMPs and TIMPs in Oral Cancer Patients on Enzyme-Linked Immunosorbent Assay (ELISA) as Compared to Immunohistochemistry (IHC)
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) show altered expression in oral cancer. MMP-3 and MMP-13 are promising diagnostic markers, while MMP-9 indicates advanced oral cancer stages.
Area Of Science
- Biochemistry
- Oncology
- Molecular Biology
Background
- Oral cancer is a significant global health burden, necessitating improved diagnostic and prognostic tools.
- Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) are implicated in cancer progression, including oral cancer.
- Understanding the expression patterns of specific MMPs and TIMPs can aid in early detection and management.
Purpose Of The Study
- To analyze the expression of MMP-1, MMP-3, MMP-9, MMP-13, TIMP-1, and TIMP-3 in oral cancer patients versus healthy controls.
- To compare the diagnostic accuracy of MMPs and TIMPs using enzyme-linked immunosorbent assay (ELISA) against immunohistochemistry (IHC).
- To evaluate the potential of these markers as diagnostic and prognostic biomarkers for oral cancer.
Main Methods
- Serum samples from 15 oral cancer patients and 14 healthy controls were analyzed using ELISA for MMP and TIMP expression.
- Tumor tissue samples underwent immunohistochemistry (IHC) analysis.
- Diagnostic accuracy (sensitivity and specificity) of ELISA results was compared with IHC findings.
Main Results
- MMPs and TIMPs showed higher expression in oral cancer patients compared to controls, with MMP-13 showing a statistically significant difference.
- MMPs and TIMPs exhibited stronger expression in advanced cancer stages via IHC, with MMP-9 showing the highest expression.
- MMP-3 and MMP-13 demonstrated the highest sensitivity and specificity on ELISA relative to IHC, identifying them as reliable diagnostic markers.
- MMP-9's elevated IHC expression in advanced stages suggests its utility as a prognostic marker.
Conclusions
- MMP-3 and MMP-13 are potential diagnostic biomarkers for oral cancer, showing high accuracy via ELISA.
- MMP-9 serves as a reliable prognostic marker, correlating with advanced oral cancer stages.
- Further research with larger cohorts is warranted to validate these findings for clinical application.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.